Investing Profile

Rajeev Shah(33)

VCInvestor
Portfolio Manager & Managing Director
racap.comBoston, Massachusetts
Photo of Rajeev Shah, Managing Director at RA Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Picture
Picture
Picture

6 Investors

Connected to Gary Swart (Polaris Partners), Navin Chaddha (The Alchemy Fund), Nitin Pachisia (Unshackled Ventures), and 3 other investors on Signal.

cb
RA Capital Managing Director
$100K - $5.0M
$1.5M
7
CompanyStageDateRound SizeTotal Raised
Black Diamond Therapeutics
Series BJan 2019$85M
$190M
Co-investors: Ali Behbahani (New Enterprise Associates (NEA)), Alexander Mayweg (Versant Ventures)
Eidos Therapeutics
Series BApr 2018$64M
$64M
Co-investors: Eric Aguiar (Aisling Capital)
Dyne Therapeutics
SeedJan 2018
$170M
Co-investors: Stefan Vitorovic (Vida Ventures), Peter Kolchinsky (RA Capital), Uciane Scarlett (MPM Capital)
Solid Biosciences
Series CMar 2017$50M
$230M
Co-investors: Luis Valdich (Citi Ventures), Adam Koppel (Bain Capital Life Sciences)
Ra Pharmaceuticals
Series BJul 2015$59M
$69M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Ali Behbahani (New Enterprise Associates (NEA))
KalVista Pharmaceuticals
Series BJul 2015$33M
$33M
Co-investors: Rich Aldrich (Longwood Fund), Bong Koh (Venrock)
Aeglea BioTherapeutics
Series BMar 2015$44M
$44M